| 
            
                 
             | 
        
Legal status
Patent not validated
| (51) | INT.CL. | C07J 31/00 | 
| (11) | Number of the document | 1474436 | 
| (13) | Kind of document | T | 
| (96) | European patent application number | 03704541.6 | 
| Date of filing the European patent application | 2003-02-03 | |
| (97) | Date of publication of the European application | 2004-11-10 | 
| (45) | Date of publication and mention of the grant of the patent | 2009-10-28 | 
| (46) | Date of publication of the claims translation | 
| (86) | Number | PCT/EP2003/001115 | 
| Date | 2003-02-03 | 
| (87) | Number | WO 2003/066653 | 
| Date | 2003-08-14 | 
| (30) | Number | Date | Country code | 
| 0202564 | 2002-02-04 | GB | 
| (72) | 
            
                 
                    
                    
                    
                    
                    Coote, Steven John, GB  
            
                
                    
                    
                    
                    
                    Nice, Rosalyn Kay, GB  
            
                
                    
                    
                    
                    
                    Wipperman, Mark David, GB  
            
         | 
    
| (73) | 
            
                GLAXO GROUP LIMITED,
                Glaxo Wellcome House,  Berkeley Avenue, Greenford, Middlesex UB6 0NN,
                GB
                 | 
    
| (54) | PROCESS FOR THE PRODUCTION OF FLUTICASONE PROPIONATE, IN PARTICULAR OF POLYMORPHIC FORM 1 | 
| PROCESS FOR THE PRODUCTION OF FLUTICASONE PROPIONATE, IN PARTICULAR OF POLYMORPHIC FORM 1 |